Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Paracortical Hyperplasia and EBV-Associated Lymphoma Risk

Clinical Presentation and Diagnosis

  • A young adult female with constitutional symptoms of fatigue and malaise for 2 weeks is consistent with infectious mononucleosis, and the primary sequela to monitor for is the potential future development of lymphoma, particularly B-cell lymphomas including Burkitt lymphoma and Hodgkin lymphoma, according to Praxis Medical Insights 1
  • Painful cervical lymphadenopathy with splenomegaly is a key feature of infectious mononucleosis, as suggested by Praxis Medical Insights 1, 2

EBV-Associated Malignancies

  • Viruses are important cofactors for many lymphoma types, and EBV infection carries specific long-term risks, including the development of Burkitt lymphoma, Hodgkin lymphoma, and diffuse large B-cell lymphoma, as reported by Modern Pathology 3, 4
  • EBV is strongly associated with Burkitt lymphoma, a type of aggressive B-cell lymphoma, according to Modern Pathology 3
  • EBV is detected in approximately 40% of classical Hodgkin lymphoma cases, as reported by Modern Pathology and Annals of Oncology 3, 5

Clinical Management Recommendations

  • Complete blood count with differential is recommended to assess for atypical lymphocytosis typical of infectious mononucleosis, as suggested by Praxis Medical Insights 1
  • Clinical follow-up every 6-12 months for the first 2-3 years is recommended to monitor for persistent or new lymphadenopathy, according to Praxis Medical Insights 1
  • Patient education about warning signs, such as painless progressive lymph node enlargement, B symptoms, or persistent fatigue, is crucial, as recommended by Praxis Medical Insights 2

Critical Pitfalls to Avoid

  • Do not dismiss persistent lymphadenopathy without proper evaluation, as this significantly increases malignancy risk, as warned by Praxis Medical Insights 1
  • Recognize that immunocompromised patients are at substantially higher risk for EBV-associated lymphoma development, as noted by Praxis Medical Insights 2